Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin
Stopped The study is being closed to accrual secondary to low accrual and an interest in opening up a different trial.
Conditions
- Invasive Bladder Cancer
- Bladder Cancer
Interventions
- DRUG: Gemcitabine and fractionated cisplatin (combination treatment)
Sponsor
Brown University
Collaborators